Status:
UNKNOWN
Thorax Computed Tomography Severity Score and Outcome in COVID-19 Patients
Lead Sponsor:
Tepecik Training and Research Hospital
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
The most common thorax Computed tomography (CT) findings are multifocal ground-glass opacities and peripheral consolidation in patients with COVID-19. Septal thickening, bronchiectasis, pleural thicke...
Detailed Description
Thorax computed tomography severity score defined by Yang et al. can be used to evaluate the severity of pulmonary involvement in COVID-19 patients. We aimed to investigate whether the initial thorax ...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- COVID-19 confirmed by positive RT-PCR and/or antibody testing
- CT scan at intensive care unit admission
Exclusion
- Loss of CT data
- Chronic lung disease findings by CT that may lead to misinterpretation
- RT-PCR results unavailable or negative
- Terminal cancer
Key Trial Info
Start Date :
March 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 15 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04424849
Start Date
March 15 2020
End Date
July 15 2020
Last Update
June 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tepecik Training and Research Hospital
Izmir, Izmir, Konak, Turkey (Türkiye), 35170